This trial is designed to see if the traditional therapy of clobetasol combined with FxCO2-laser therapy is more effective than just FxCO2-laser therapy alone in women with vulvar lichen sclerosus.
1 Primary · 6 Secondary · Reporting Duration: About 5 months (baseline to final visit)
184 Total Participants · 2 Treatment Groups
Primary Treatment: Clobetasol Group · Has Placebo Group · Phase 4
Age 18+ · Female Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|The University of New Mexico||100.0%|
|Did not meet criteria||50.0%|